Skip to main content
Phase-3 study: Leukemia patients live longer with ibrutinib
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase-3 study: Leukemia patients live longer with ibrutinib
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Leukemia
0
0.77
Adverse Effects
0
0.48
Patient Safety
0
0.36
Remission
0
0.29
Genomic Medicine
0
0.99
Blood
0
0.19
Chemotherapy
0
0.19
Toxicology
0
0.14
Antineoplastic Drug
0
0.1
California
0
0.1
Europe
0
0.1
Monoclonal Antibody
0
0.1
Atrial Fibrillation
0
0.07
Biologic Therapy
0
0.07
Hypertension
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Edit Tags